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Abstract
Purpose:  The  current  gold  standard  treatment  of  localized  painful  bone  lesion  is  radiotherapy
but this  technique  has  limitations.  Our  study  aims  to  demonstrate  that  cementoplasty  is  an
efﬁcient  alternative  for  these  palliatives  indications  when  lesions  involve  extraspinal  bones.
We prospectively  followed  20  patients  who  received  a  percutaneous  cementoplasty  on  painful
lytic bone  lesions  between  May  2008  and  May  2010.
Materials:  Seventeen  patients  also  had  difﬁculty  walking  in  relation  to  the  pain  experienced.
The clinical  indication  for  treatment  was  severe  pain  (≥  4  on  the  numeric  scale)  due  to  bone
lesion on  CT  or  MRI.  All  procedures  (except  one)  were  performed  under  local  anesthesia.
Results:  Feasibility  was  100%  without  immediate  complications.  The  patients  experienced  a
signiﬁcant and  rapid  decrease  of  their  pain  (4.1  points,  P  <  000.1)  and  this  effect  was  sustained
over the  long  term  (7.75  months  of  follow-up  on  average).  Sixty-four  percent  of  patients  treated
on the  lower  limbs  and  pelvis  improved  mobility.
Conclusion:  In  our  experience,  percutaneous  cementoplasty  may  be  a  safe  and  effective  pallia-
tive treatment  for  localized  painful  lytic  lesion.  Combining  CT  and  ﬂuoroscopic  guidance  seems
to be  the  safer  option  because  of  extravertebral  localization.  Smart  ﬁll  of  the  bone  and  careful
selection of  patient  determine  the  effectiveness  of  the  procedure.  Diffuse  painful  lesions  and
long bone  diaphysis  should  not  be  good  indications.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.Bone  lesions  always  raise  two  fundamental  questions  for  the  patient:  pain  and  risk  of
fracture.  When  surgery  is  not  possible,  the  use  of  cement  is  a  good  answer  to  both  prob-
lems.  Indeed,  its  stabilization  properties  were  initially  used  in  orthopedic  practice  while
percutaneous  intravertebral  injection  under  radiology  guidance  has  been  ﬁrst  introduced
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Figure 1. Patient 5. a, b: lytic lesion of the medial condyle of the femur in the coronaland axial; c: 22-gauge needle for periosteal
anesthesia; d: coaxial trocar penetration; e: cement injection and veriﬁcation of distributed CT and ﬂuoroscopy (not shown); f: condylarlytic
zone subjected to compressive stresses ﬁlled by cement. The ﬁlling of the area allows a consolidation also reducing the risk of fracture; g:
pain follow-up shows progressive and lasting disappearance of symptom.
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Table  1 Characteristics  of  patients.
No.  Site  Inclusion  Age,  sex  Primary  Imaging  Localisation  Other  lesions
1  3  04/06/09  70  M  Pulmonary  CT  Humerus  left  Costal
2  1  11/06/09  66  F  Mm  CT  Sacrum  left  Vertebrae
3  3  11/06/09  52  F  Breast  CT  Humerus  left  Vertebrae
4  3  02/07/09  65  F  Breast  CT  Ileum  left  No
5 1  18/06/09  63  F  Mm  CT  Femur  left  medial  condyle  Vertebrae
6 1 18/06/09 82  F Breast  CT  Ileum  right  Vertebrae
7 1 18/06/09 65  F Mm MRI Humerus  left  Vertebrae
8 1 02/07/09 69  F Mm (plasmacytoma) CT Acetabulum  left No
9  1  22/07/09  60  F  Ovarian  CT  Femur  right  (neck)  Ileum
10  1  22/07/09  69  M  Mm  CT  Sacrum  right  Vertebrae
11  1  24/09/09  68  F  Breast  CT  Ileum  left  Vertebrae
12  1  30/09/09  67  F  Mm  CT  Acetabulum  left  Vertebrae
13  1  29/10/09  51  F  Cervical  cancer  CT  Sacrum  left  No
14  1  05/11/09  59  M  Mm  (plasmacytoma)  CT  Fibula  left  Vertebrae
15  1  18/11/09  77  M  Unknown  CT  Femur  left  No
16  3  15/12/09  51  M  Bladder  CT  Sacrum  right  Sacrum  left
17  3  19/01/10  75  M  Colon  CT  Ileum  left  Ileum
18  2  20/02/10  85  F  Pulmonary  CT  Acetabulum  left  Vertebrae
19  1  25/03/10  76  F  Breast  CT  Acetabulum  right  Vertebrae
20  1  25/03/10  76  M  Pulmonary  CT  Ileum  left  No
No.  Local  extension  Mean  diameter  NS  BP  RT  delay  Analgesic
WHO
1 Cortical  rupture 25  6  No  No  3
2 No  cortical  rupture 30 5.5  No  No  2
3 No  cortical  rupture 15  5  No  Yes  -  1  y  2
4 Cortical  rupture 27 6  No  Yes  -  1  y  2
5 No  cortical  rupture 25  8  No  No  3
6 No  cortical  rupture 25 4.5  Yes  No  3
7 No  cortical  rupture 18 5 No  No  0
8 Cortical  rupture 33 5 No No  2
9  Neck  fracture  34  8  Yes  Yes  -  1  y  2
10  Cortical  rupture  28  6  Yes  Yes  -  2  m  3
11  No  cortical  rupture  25  6  Yes  Yes  -  10  y  1
12  No  cortical  rupture  31  10  No  Yes  +10  d  1
13  Cortical  rupture  73  4  No  Yes  +7  d  3
14  Cortical  rupture  26  6  No  No  2
15  No  cortical  rupture  60  5  Yes  No  2
16  Cortical  rupture  15  7  No  Yes  -  1  y  3
17  Cortical  rupture  30  8  No  Yes  +7  d  3
18  Cortical  rupture  18  10  No  No  2
19  Cortical  rupture  29  5  Yes  No  2
20  Cortical  rupture  20  8  Yes  Yes  -1  m  3
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PMm: myeloma; NS: Numeric Scale of Pain; BP: biphosphonates; RT
to  treat  angioma  in  1984  [1,2]. Known  as  vertebroplasty,
this  technique  spread  to  spine  metastasis  and  osteoporosis
fractures  indication  with  many  existing  series  in  the  litera-
ture  [3—5]. Much  less  series  concern  the  cementoplasty  on
extraspinal  lesions.  The  current  gold  standard  treatment  of
painful  bone  metastases  is  radiotherapy  and  analgesic  indi-
cation  is  an  important  part  in  the  daily  practice  in  radiation
therapy  units.  Unfortunately,  treatment  effects  appear  only
15  days  after  the  start  of  treatment  and  leave  around  30%  of
patients  incompletely  relieved  [6].  This  paper  demonstrates
our  experience  of  interventional  analgesic  treatment  of
T
F
2iotherapy. Diameter in millimeters, WHO-levels analgesics.
on-vertebral  lytic  bone  lesions  by  cementoplasty.  First  out-
ome  was  the  signiﬁcant  analgesic  effect  of  this  technique
nd  second  outcome  was  mobility  improving.
atients and methodsype of study and population
rom  May  2008  to  May  2010,  we  prospectively  followed
0  patients  with  lytic  hyperalgesic  (≥  4  on  Numeric  Scale)
862  
Figure 2. Charts of average pain felt by the patient after cemen-
toplasty on numerical scale (NS). Histograms of mean reduction
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mn pain after treatment on NS. The nadir of the curve is located
t 1 month and the analgesic effect is long lasting. The treatment
mmediately reduced the pain (4 points on average).
one  lesions  treated  on  a  tri-centric  technical  platform.
xclusion  criteria  were  systemic  contraindication.  The  indi-
ation  was  based  on  imaging  which  highlighted  one  or
ore  extravertebral  lytic  bone  lesions  associated  or  not
ith  extra  bone  invasion  or  fracture.  Selection  of  par-
icipants  was  therefore  established  by  a  multidisciplinary
anel  of  practitioners  on  a  proper  relationship  between  the
ain  symptoms  and  the  imaging.  Patient  characteristics  are
ummarized  in  Table  1:  average  age  was  67  years  old;  eti-
logy  was  metastatic  in  13  patients  and  myeloma  in  seven
atients;  average  diameter  of  lesions  in  the  three  axes  was
9  mm  (15—73).
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igure 3. Flow Chart of bone metastasis and normal distribution re
etastases. Haematopoietic marrow lies in the skull, vertebrae, ﬂat b
etastases preferentially reach skeletal hyper vascularized areas of redA.  Iannessi  et  al.
escription of the procedure [7]
ll  procedures  were  performed  under  local  anesthesia
xcept  one  (patient  No.  18).  They  were  performed  under  ﬂu-
roscopy  (GE  Stenoscope  C-arm)  and  CT  Scan  (LightSpeed8,
E  Medical  Systems,  Milwaukee,  WI)  at  site  1;  under  CT
lone  (Brilliance  8;  Philips,  The  Netherlands)  at  site  2  and
nder  ﬂuoroscopy  alone  (XperAllura,  Philips)  at  site  3.  A  long
2-gauge  needle  was  inserted  until  contact  with  bone  to
llow  anesthesia  on  the  route  and  at  the  periosteum.  Then,  a
1-gauge  trocar  vertebroplasty  (Osteo-site® Cook  11G)  was
nserted  into  the  lytic  lesion  (Fig.  1).  Imaging  control  was
ealized  to  verify  its  correct  position.  The  cement  (Osteoﬁrm
ook®)  was  injected  pasty  under  imaging  control.  Injection
as  stopped  when  the  distribution  was  satisfactory  or  when
 leak  was  detected.
ata collection
ll  the  data  were  collected  by  radiologist  by  phone  or  live
nterview.  Hospital  Anxiety  and  Depression  scale  (HAD)  has
een  collected  before  carrying  out  the  procedure  to  ana-
yze  the  psychological  proﬁle  of  the  treated  population
8].  During  the  procedure,  the  experienced  pain  and  ﬁll-
ng  of  lesion  were  analyzed.  After  the  procedure,  patients
ere  followed  clinically  at  1  day,  1  week  and  then  monthly
8  months  on  average).  Pain  intensity  (Numerical  Scale,
S)  and  functional  improvement  for  pelvis  or  lower  limbs
esions  responsible  for  impairment  were  collected.  The
coring  was  performed  using  items  of  the  Functional  Inde-
endence  Measure  (FIM)  score  on  mobility,  toileting  and
d marrow in adulthood correlated with the percentage of bone
ones, the proximal metaphysis of the femur and humerus. Bone
 marrow.
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Table  2  Results.
No.  Position  Time  %  Filling  (<  50%:  1,
≥  50%:  2)
Cement
quantity
NS  (P)  NS  (D0)  NS  (D1)  NS  (D7)  NS  (M1)  NS  (M3)  NS  (M6)
1 S 20  2  4  2  6  1  0  0  0
2  P  20  2  5  3  5.5  1  0  0  0  0
3  S  20  2  2  3  5  0  0  0  0  0
4  P  30  2  3  3  6  1  0  0  0  0
5 S 30 2  5  4  8  2  1  0  0  0
6 P 60 2 4.5  2  4.5  1  0  0  0  0
7 S 30 2 3 7 5 1 0  0  0  0
8 P 40 2 10 6 5 7 0 0 0 0
9  P  30  2  3  2  8  1  1  1  1  0
10  P  30  2  3  5  6  4  0  0  0  0
11  S  30  2  3  5  6  5  5  5  6  5
12  S  20  1  3  3  10  2  0  0  0  0
13 P 30 1 7 6 4 1  0  0  0  0
14 S 30 2 7 8 6 0  0  0  0  0
15  S  30  1  6  6  5  8  1  1  1  1
16  P  20  1  3  2  7  2  1  1  1  1
17  P  20  1  3  2  8  4  2  0  0
18  S  40  2  4  GA  10  5  0  0  1
19  S  30  1  3  4  5  0  0  0  0
20  S  20  2  5  2  8  0  2  0  0
No.  NS  (E)  Death  (n  M)  WHO  MIF  before  MIF  after  MIF  HAD  (A)  HAD  (D)  PGIC  (M3)
1 0 5 0  7  4  1
2 0 +1 22221  22222  Yes  9  5  1
3 0 0  9  6  1
4 0 0 22111  22211  Yes  8  4  1
5 0 −1  22221  22222  Yes  16  9  1
6 0 0 12211  22221  Yes  8  5  2
7 0 +1 8 5  2
8 0 0 22222 22222 No  9  4  1
9  0  5  +1  22211  22211  No  10  13  1
10  0  6  0  22111  22222  Yes  7  7  1
11  5  +2  22211  22211  No  6  3  4
12  0  5  +2  11111  12111  Yes  8  3  1
13  0  −1  10110  12110  Yes  12  8  1
14  0  −1  22211  22222  Yes  7  5  1
15  1  0  12111  12111  No  4  1  4
16  1  0  11111  12211  Yes  9  10  1
17  0  4  0  21211  22221  Yes  6  6  1
18  1  0  22222  22222  No  5  5  1
19  0  +1  12010  12110  Yes  8  4  1
20  0  0  22222  22222  0  6  6  1
S: Supine; P: Prone; NS: Numeric Scale of pain; MIF: Functional Independence Measure; HAD: Hospital anxiety (A) and Depression (D)
scale; Procedure time (min), Quantity (ml); WHO: change of analgesic WHO-level; MIF: Numeric data corresponding from 0 to 2
corresponding to these respective items Toilet/Sit position/Stand position/Walk/Staircase (scored from 0—2 based on the capacity: 0
being totally disabled, 1 is the ability with help, 2 being autonomous).
P
Clocomotion  [9,10]. We  also  recorded  WHO-class  painkillers
administered  and  after  3  months,  each  patient  was  asked
about  his  satisfaction  with  the  cementoplasty  using  the
score  of  Patient’s  Global  Impression  of  Change  (PGIC)
on  pain  [11,12].  No  speciﬁc  radiological  monitoring  was
performed.
g
o
mresentation of results
linical  success  was  deﬁned  as  improvement  of  pain  score
reater  or  equal  to  2  points  on  NS  and  as  an  improvement
f  greater  or  equal  to  1  point  on  functional  independence
easure  [11,13].  According  international  consensus,  we
864  A.  Iannessi  et  al.
Figure 4. Patient 14. a, b: CT scan MPR coronal and axial view; c, d: cement injection under control CT and ﬂuoroscopy; e: CT scan VR
after cementoplasty. The lytic lesion of the distal metaphysis of the ﬁbula leads to a major risk of fracture. The distribution of cement in
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The lesion that allowed a bone consolidation face to the compressiv
f symptom.
istinguish  complete  response  (CR)  (pain  after  proce-
ure  =  0)  and  partial  response  (PR)  (pain  reduction  of  ≥  2
oints)  [14]. Cementoplasty  was  felt  to  be  effective  in
atients  who  had  a  PGIC  score  less  or  equal  to  3.
tatistical analysis survival  rate  was  calculated  by  Kaplan-Meier  method.
e  used  the  Wilcoxon  Mann-Whitney  nonparametric  paired
ethod  to  assess  pain  improvement.  A  Spearman  correlation
T
D
T
(sses; f: pain follow-up shows immediate and lasting disappearance
est  (nonparametric)  was  conducted  between  cement  vol-
me  and  tumor  size.
esults
he  mean  survival  rate  at  12  months  was  70%  (Table  2).
he  feasibility  was  100%  under  local  or  general  anesthesia.
uring  the  procedure,  pain  experienced  was  4  on  average.
he  mean  volume  of  cement  injected  was  4.3  ml  in  average
4—10  ml)  and  70%  of  the  lesions  were  ﬁlled  to  more  than
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Figure 5. Patient 15. a, b: CT scan MPR coronal and axial view shows lytic lesion of the proximal femur diaphysis with posterior cortical
disruption (arrow); c, d: ﬁne needle enable periosteal anesthesia for intramedullary penetration of the needle for cementoplasty; e:
ﬂuoroscopic guidance; f: CT scan MPR coronal view after injection. The cement was distributed only in the upper part of the lesion. This
ﬁlling is insufﬁcient to expect a consolidation. Signiﬁcant decrease in background pain despite incomplete ﬁlling. The patient is warned of
 redu
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Bthe risk of fracture during the handing over. The treatment did not
50%  of  cement.  We  had  only  one  leakage  of  cement  and
it  was  along  the  path  of  puncture.  There  were  no  major
complications  according  consensus  classiﬁcation  [15]. We
didn’t  experienced  refracture  of  cement.
Before  treatment,  average  pain  was  6.4.  During  follow-
up,  the  response  was  signiﬁcant  in  a  short  time  as  the
average  score  on  NS  fell  from  6.4  to  2.3  (P  <  0.001)  in
24  hours.  The  analgesic  response  was  4.1  points  on  average.
The  maximum  efﬁciency  was  obtained  at  1  month  with  a  CR
in  80%  patients  and  pain  less  than  2  in  other  patients.  Two
patients  did  not  improve  and  had  a  PGIC  score  greater  than
or  equal  to  4  (patient  11  and  15).  Seventeen  patients  had
F
l
(
ice the pain induced by movement (g).
ifﬁculty  walking.  Among  them,  11  patients  (64%)  treated
mproved  signiﬁcantly  their  mobility.  Reducing  pain  of  one
HO-level  was  observed  in  only  one  patient.
iscussion
one  pain  and  metastases  discussion  is  summarized  in
igs.  2  and  3.  Bone  metastases  are  a public  health  prob-
em  because  cancer  overall  incidence  is  still  increasing
3.2  million/year)  and  because  the  skeleton  is  the  third
ncident  site  for  metastasis  after  lung  and  liver  [16,17].
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rigure 6. Biomechanical properties of bone cement.
steolytic  lesions  predominate  (80%  due  to  prostate,  breast
nd  lung  cancers)  and  myeloma  malignancy  is  the  most  fre-
uent  cause  of  lytic  bone  lesions  [18—20].
Bone  lesions  affect  the  quality  of  life  of  the  patient
ausing  intractable  pain,  nerve  compression,  pathological
ractures  and  decreased  mobility.  All  these  complications
re  a  source  of  anxiety  and  depression  as  a  complication  of
one  metastases  in  both  serious  and  costly  [17].
Bone  metastases  are  preferentially  located  in  areas  of
ed  marrow  where  blood  ﬂow  is  higher  that  is  why  two
hrids  of  lesions  are  extraspinal  [19,21,22]. Pain  is  not
orrelated  to  the  degree  of  bone  injury  and  the  mecha-
isms  are  incompletely  understood.  Some  were  identiﬁed
s  stress-related  periosteal  tumor  development,  microfrac-
ures  and  macro-fractures,  cytokines  mediating  osteoclast,
he  accompanying  nerve  damage  of  the  periosteum  and
urrounding  tissues  [17,23—25].  However,  it  explains  why
one  pain  has  two  components:  a  painful  background  and
cute  peaks  during  movement.  The  management  of  painful
one  metastases  combines  systemic  and  local  therapies.  It
s  justiﬁed  because  quality  of  life  is  at  least  as  important
s  the  prognosis  for  these  patients.  Bisphosphonates,  hor-
one  therapy  and  chemotherapy  have  a  delayed  effect  [26].
nly  analgesics  have  an  immediate  beneﬁt  that  is  why  they
emain  for  many  patients  the  ultimate  therapeutic  option.
evertheless,  if  background  pain  is  usually  fairly  controlled,
he  pain  induced  by  movement  requires  higher  doses  leading
o  adverse  events  [27,28].
When  a  localized  painful  lesion  is  identiﬁed,  surgery  is
arely  a  satisfactory  therapeutic  option  because  it  is  often
 too  invasive  option  on  a  fragile  patient.  Fractures  ﬁx-
tion  ordinarily  may  be  accomplished  with  minimal  blood
oss  or  morbidity.  In  fact,  fractures  or  impending  fractures
nvolving  the  acetabulum  necessitate  extensive  joint  recon-
truction,  with  inherent  increased  potential  for  morbidity
nd  complications  [29]. Radiotherapy  is  a  good  solution
ut  it  has  three  limitations.  First,  it  is  often  unsatisfying
ecause  40%  of  patients  have  no  response  and  only  30%  have
R  according  to  recent  data  from  the  literature  [6].  Then,
ffect  is  delayed  about  15  days  because  of  the  mechanism
f  apoptosis.  Finally,  because  of  tissue  tolerance,  it  can  be
sed  only  once.  The  vertebroplasty  is  also  a  minimal  invasive
ocal  therapy.  It  proved  its  efﬁcacy  in  benign  and  malignant
h
[
cathology  by  allowing  healing  and  pain  control  [1,4,5].  The
ementoplasty  in  extraspinal  bone  tumors  is  less  studied
30,31].
Regarding  pain  results,  one  third  of  patients  experienced
ntense  pain  (>  4)  during  the  procedure  which  encourages
 preference  for  sedation  or  general  anesthesia  if  possi-
le.  The  cementoplasty  analgesic  effect  is  major,  fast  and
aintained.  Cement  necrotizing  and  embolization  proper-
ies  on  afferents  responsible  for  nerve  pain  are  involved
n  the  efﬁciency  mechanism.  Moreover  it  is  likely  complex
nvolving  a  mechanical  consolidation  of  the  bone  reducing
eriosteum  stress  [32]. This  explains  the  effectiveness  of
he  technique  both  on  background  pain  and  on  kinetic  pain.
s  already  shown  in  the  literature  we  have  not  found  any
elationship  between  tumor  volume  ﬁlling  and  reduction  of
ain  (<  50%  or  >  50%,  P  =  0.802  the  ﬁrst  month)  [31]. But
onsidering  kinetic  component,  we  assume  that  the  quality
f  the  padding  is  important  to  maximize  analgesic  effect  by
onsolidating  bearing  areas  subjected  to  mechanical  stress
33]  (Fig.  6).  The  patient  11  in  whom  the  procedure  did
ot  work  involved  a  pelvic  pain  irradiating  to  the  lower
imb.  Retrospectively,  the  pain  was  probably  related  to
adiation-induced  neuropathy  showing  the  importance  of
re-procedural  patient  clinical  examination.  Clinically  bone
ain  is  generally  projected  next  to  the  anatomical  region  and
ypically  increased  by  focal  pressure.  The  series  published
n  extraspinal  cementoplasty  are  few  but  their  results  are
onsistent  with  our  observations  showing  pain  reduction  in
bout  80%  cases  [27,31—33].
Considering  the  mobility,  one  third  of  lesions  affect  pelvic
one  or  lower  limb  so  they  cause  a  rapid  reduction  in  mobil-
ty  and  reduce  quality  of  life.  In  our  series  we  show  an
mprovement  of  mobility  for  two  thirds  of  patients  who  had  a
isability  before  cementoplasty  and  over  80%  of  patients  are
mproved  on  items  concerning  locomotion.  On  this  point,  our
esults  are  consistent  with  observations  previously  published
y  Basile  et  al.  and  Marcy  et  al.  [31,33].
Regarding  complications,  they  are  stratiﬁed  according
ociety  of  International  Radiology  classiﬁcation  [15]. The
isk  of  bleeding  is  greater  during  needle  insertion  and  with
yper  vascular  metastasis  (thyroid,  kidney,  and  melanoma)
34,35].  In  these  cases,  it  is  recommended  to  maintain
ompression  for  5  minutes  [36]. During  injection,  it  is
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Figure 7. Patient 19. a, b: CT scan MPR coronal and axial view showing lytic lesion with involvement of the acetabulum roof (arrow)
and columns (stars); c, d: CT scan placement of the needle for cement injection into the roof of the acetabulum and cement injection
control; e: CT scan VR showing a consolidation of the acetabular roof while the ﬁlling of the lesion is incomplete. Signiﬁcant reduction in
pain despite the incomplete ﬁlling of the lesion (f). We made the choice to consolidate the area subject to higher compressive stresses.
The gain on mobility is signiﬁcant.
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ifﬁcult  to  predict  cement’s  distribution  [37]. There  is  a  risk
f  leakage  which  can  be  problematic  when  intra-articular,
n  contact  with  a  nerve  trunk  or  on  a  support  zone  (Fig.  4).
n  other  cases,  it  does  not  need  treatment.  Notice  that
ontact  neuralgia  is  accessible  to  inﬁltration  of  cortisone.
s  the  rupture  of  the  posterior  wall  was  once  a  contraindi-
ation  for  vertebroplasty,  it  is  no  longer  so  today  with  the
mprovement  of  the  technique.  As  the  same,  we  believe  a
hick  consistency  of  the  cement  and  real-time  ﬂuoroscopic
maging  minimizes  the  risk  of  leakage  outside  close  joint
ine  metastases  (Fig.  5).  In  any  case  if  osteolysis  adjacent
o  the  joint,  injection  must  be  extremely  careful  to  avoid
he  risk  of  rapid  chondrolysis  when  intra-articular  leakage
38].  Note  that  the  anatomical  conﬁguration  of  extraspinal
esions  needs  a  three-dimensional  vision.  Thus,  we  believe
hat  a  combination  of  CT  and  ﬂuoroscopic  guidance  makes
he  procedure  safer.
When  cancer  affects  patients,  they  often  acquired  bone
arrow  failure  due  to  disease  itself  or  chemotherapy  [39].
n  these  conditions,  It  seems  legitimate  to  consider  these
atients  at  high  risk  of  infectious  complications  and  to
imit  this  risk  by  providing  a  systematic  antibiotic  prophy-
axis  (cefazolin  [1  g]  as  ﬁrst-line).  Moreover  some  authors
dvocate  the  use  of  antibiotic  loaded  cement  in  immuno-
uppressed  patients  [40,41].  High  hygiene  precautions  are
lso  necessary  because  the  injection  of  cement  is  related  to
he  establishment  of  an  orthopedic  implant  with  the  differ-
nce  that  you  can  hardly  remove  it  if  infected  [37,40,42].
he  overall  rate  of  infectious  complications  reported  is  less
han  1%.  Biomechanical  properties  of  cement  are  perfectly
dapted  to  withstand  compression  fractures  that  occur  in
he  ﬂat  bones  and  bearing  joints  such  as  the  vertebrae,  the
cetabulum,  and  the  femoral  condyle  (Fig.  1).  We  treated
 lytic  lesion  of  the  peroneal  malleolus  with  a  satisfactory
lling  of  the  tumor  (patient  14)  and  in  this  case,  we  can
ssume  that  the  risk  of  fracture  is  reduced  by  restoring  bone
trength  to  face  constraints  in  compression  (Fig.  5).  How-
ver,  resistances  to  twisting  stresses  are  low  so  it  cannot
educe  the  risk  of  fracture  of  lytic  diaphyseal  lesion  (Fig.  6)
43,44].  It  seems  reasonable  to  reserve  this  indication  as  pal-
iative  and  inform  the  patient  of  the  persistence  of  risk  of
racture  (Fig.  7).  If  stabilization  is  necessary,  osteosynthe-
is  should  be  preferred.  Noticethat  the  injection  of  cement
ay  interfere  signiﬁcantly  with  surgery  which  may  be  neces-
ary  thereafter  [42,45,46]. Treatment  of  diaphysis  should  be
nly  considered  for  advance  palliative  cases  when  surgery  is
ontra  indicated.
The  clinical  impression  of  change  (PGIC)  shows  that
0%  of  patients  feel  positive  change  after  the  procedure
hich  corroborates  the  results  for  pain.  Patient  15  was
ot  completely  satisﬁed  because  of  persistent  kinetic  pain
espite  the  signiﬁcant  analgesic  response  on  background
ain  (Fig.  5).  As  explained,  we  assume  that  mobility  non-
mprovement  was  due  to  incomplete  ﬁlling  of  the  lesion
hat  could  not  provide  a  good  biomechanical  stabiliza-
ion.  More  than  a  half  of  our  patients  have  symptoms
f  anxiety  (60%)  or  depression  (20%)  according  to  HAD
core.  We  imagine  it  interferes  with  pain  feeling  and  the
ffectiveness  impression  of  the  procedure  even  if  no  sig-
iﬁcant  difference  has  been  showed.  The  vertebroplasty  is
ot  considered  a  technique  of  percutaneous  tumor  abla-
ion  in  the  strict  sense.  Some  authors  have  studied  the
p
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eat  of  the  cement  during  its  polymerization  to  investi-
ate  the  effect  of  hypothetic  thermal  ablation.  It  is  clear
hat  this  relative  effect  is  certainly  not  able  to  have  an
ncologic  action  alone  and  one  should  consider  cemento-
lasty  for  analgesia  or  stabilizing  only  [47,48]. Although
n  our  series  we  did  not  observe  any  recurrent  disease,
ome  patients  have  received  treatment  with  radiotherapy
nd  all  were  treated  with  chemotherapy.  If  the  thera-
eutic  intent  is  carcinologic  treatment,  association  with  a
hermal  ablation  technique  such  as  cryotherapy  or  radiofre-
uency  ablation  should  be  considered  [43,45,46]. However,
or  analgesic  action,  recent  studies  show  no  superiority  of
adiofrequency  +  cementoplasty  versus  cementoplasty  alone
n  the  treatment  of  small  tumors  [23,32]. It  seems  legiti-
ate  to  combine  thermal  ablation  technique  when  tumor
nvolves  the  surrounding  soft  tissues.  However,  cemen-
oplasty  appears  to  be  most  effective  in  terms  of  pain
anagement  for  weight-bearing  bones,  probably  due  to  its
tabilizing  action  [40,48,49].
Our study  has  a  recruitment  bias  related  to  a  majority  of
omen  but  existing  studies  have  however  no  sex  difference
27,31—33].  The  dose  reduction  of  analgesic  and  WHO-level
re  not  good  indicators  of  the  effectiveness  excluding  ﬁve
atients  with  a  single  lesion.  For  them,  there  is  no  notice-
ble  increase  in  the  WHO-level  prescribed  painkillers  and
ne  resulted  in  a  decrease  (patient  13).  In  fact,  cemento-
lasty  allow  controlling  pain  locally  identiﬁed  while  other
ainful  lesions  may  require  the  taking  of  analgesics  inde-
endently  of  the  targeted  lesion.  Despite  the  diversity  of
roups,  if  we  compare  the  analgesic  efﬁcacy  in  the  group
ith  multiple  myeloma  and  solid  tumor  it  does  not  show
igniﬁcant  difference.  However,  one  can  assume  that  there
ust  be  differences  in  the  long  term  given  the  differences
n  aggressiveness.  Masala  et  al.  report  their  experience
n  treating  extraspinal  injuries  myeloma  and  get  similar
esults  in  terms  of  analgesic  efﬁcacy  [50]. We  deliberately
estricted  the  selection  of  patients  with  lytic  tumors  to  pro-
ote  efﬁciency  of  the  procedure  by  optimizing  the  ﬁlling  of
he  lesion.  Cementoplasty  is  not  a  suitable  technique  to  pure
steoblastic  lesions  because  the  injection  is  under  heavy
ressure  that  makes  difﬁcult  to  control  proper  distribution
f  cement  [48,51].
onclusion
n  our  experience,  the  percutaneous  cementoplasty  is  an
ffective  palliative  treatment  that  can  be  considered  at
he  forefront  for  pain  management  of  many  osteolytic
xtraspinal  bone  tumors.  It  is  safe  and  fast  effect.  It  also
llows  consolidation  of  the  bone  and  improved  patient
obility.  Criteria  for  successful  procedure  include  proper
atient’s  selection  with  precise  clinical  exam  of  eligible
atients:  it  is  particularly  indicated  to  oligometastastic
atient  with  a well-identiﬁed  osseous  pain.  It  includes  also
roper  lesion  selection  because  acrylic  cement  is  adapted
o  ﬂat  bones  and  ﬁlling  priority  areas  of  constraints  helps
revent  fractures  in  compression.
Criteria  for  safe  procedure  include  careful  cement  injec-
ion  when  lesion  is  surrounding  bone  joint  and  optimal
uidance  with  combined  CT  scan  and  ﬂuoroscopy.
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